Healthcare IT market in emerging economies to double by 2015

Keith Moore | | Health Imaging | Oncology Imaging
Research and Markets has published “Healthcare IT Market in Emerging Economies (2010-2015),” which cites the growth of medical tourism, demand for better quality healthcare delivery by a growing aging population and an increase in the chronic disease patient population as driving the increased adoption of IT in emerging markets.

The Dublin, Ireland-based research firm expects the healthcare IT market in emerging economies to grow from $5.3 billion in 2010 to $10.9 billion in 2015, at an estimated compound annual growth rate of 15.3 percent from 2010 to 2015. The hardware segment dominates the healthcare IT market in emerging economies and is expected to be the fastest growing segment for the next five to seven years, according to the report.

Keith Moore

Related Content

High-intensity focused ultrasound could allow prostate cancer patients to avoid surgery
MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.